Show simple item record

dc.contributor.authorNgetich, Ronald
dc.date.accessioned2017-01-05T08:26:00Z
dc.date.available2017-01-05T08:26:00Z
dc.date.issued2016
dc.identifier.urihttp://hdl.handle.net/11295/99100
dc.description.abstractThe topic entails various strategies aligned by Dawa pharmaceuticals limited in order to be competitive in the pharmaceutical industry. The strategies are linked together as they must go hand in hand in order to meet the organization objectives. The pharmaceutical industry has become vibrant especially in Kenya as focus is on devolution of healthcare to counties. In this case, various pharmaceutical companies have to come with various strategies in order to be relevant and to survive the competitive tides. The strategies include diversification, financing, value chain, marketing, customer focus, supply chain strategies among others. For example diversification may involve dealing with various products apart from human medicine but also animal drugs. This is a means of widening the market share. It also refers to expanding business fields to new markets. Supply chain strategy focuses on the procuring and distribution of drugs to the clients considering various factors such as mode of transport, lead time and flexibility. Value chain as well elaborates linking of various activities the organization performs to its competitive position and this offers competitive advantages. In addition, the topic describes the challenges faced by Dawa in implementing various strategies and how they overcome, what impact these challenges have on the overall performance of the company and various strengths, weaknesses, opportunities and threats that are faced by the organization. The challenges are aligned mostly to competition from the giant pharmaceutical industries. In conclusion, healthcare function in Kenya is devolved. This call for generation of strategies in a wider perspective, e.g. marketing, customer focus, partnerships with distributors, doctors, hospitals, pharmacies and medical representatives. This will enable easier market penetration in order to remain competitive and relevant. Other strategies include growth and expansion strategies, information and communication strategies.en_US
dc.language.isoenen_US
dc.publisherUniversity Of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectKenyan Pharmaceutical Industryen_US
dc.titleStrategies Used by Dawa Limited to Compete in the Kenyan Pharmaceutical Industryen_US
dc.typeThesisen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States